In addition, prevalence of type 2 DM, overweight/obesity, nephropathy, neuropathy, and prescription of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers, statin and metformin for patients with GLS < 18% were significantly higher than for those with GLS ≥ 18%. This evidence concerns the gene ACE and Nephropathy.